GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hexima Ltd (ASX:HXL) » Definitions » Net Cash per Share

Hexima (ASX:HXL) Net Cash per Share : A$0.01 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Hexima Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Hexima's Net Cash per Share for the quarter that ended in Dec. 2023 was A$0.01.

The historical rank and industry rank for Hexima's Net Cash per Share or its related term are showing as below:

ASX:HXL' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.2   Med: 2.1   Max: 13.83
Current: 1.2

During the past 7 years, the highest Price-to-Net-Cash Ratio of Hexima was 13.83. The lowest was 1.20. And the median was 2.10.

ASX:HXL's Price-to-Net-Cash is ranked better than
83.58% of 865 companies
in the Biotechnology industry
Industry Median: 4.14 vs ASX:HXL: 1.20

Hexima Net Cash per Share Historical Data

The historical data trend for Hexima's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hexima Net Cash per Share Chart

Hexima Annual Data
Trend Jun08 Jun09 Jun10 Jun20 Jun21 Jun22 Jun23
Net Cash per Share
Get a 7-Day Free Trial 0.25 0.04 -0.02 -0.01 0.01

Hexima Semi-Annual Data
Dec06 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 -0.01 0.01 0.01 0.01

Competitive Comparison of Hexima's Net Cash per Share

For the Biotechnology subindustry, Hexima's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hexima's Price-to-Net-Cash Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hexima's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Hexima's Price-to-Net-Cash falls into.



Hexima Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Hexima's Net Cash per Share for the fiscal year that ended in Jun. 2023 is calculated as

Net Cash per Share (A: Jun. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(2.189-0.174-0)/167.04
=0.01

Hexima's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(1.913-0.106-0)/167.04
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hexima  (ASX:HXL) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Hexima Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Hexima's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hexima (ASX:HXL) Business Description

Traded in Other Exchanges
N/A
Address
84-90 Hotham Street, Corporate One, Preston, VIC, AUS, 3072
Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.

Hexima (ASX:HXL) Headlines

From GuruFocus

Hexcel Declares Quarterly Dividend

By Business Wire 07-24-2023

Hexcel Schedules Third Quarter 2020 Earnings Release and Conference Call

By Business Wire Business Wire 10-01-2020

Top 5 4th Quarter Trades of Bouvel Investment Partners, LLC

By GuruFocus Research GuruFocus Editor 01-19-2023

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 04-25-2022

Hexcel Schedules First Quarter 2022 Earnings Release and Conference Call

By Business Wire Business Wire 04-01-2022

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 10-24-2022